Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.6 USD | -0.08% |
|
-3.82% | -11.70% |
06-21 | Takeda Secures European Commission's Approval for Colorectal Cancer Drug Fruzaqla | MT |
06-21 | Takeda Pharmaceutical Gets European Commission Approval for Cancer Treatment | DJ |
Evolution of the average Target Price on Takeda Pharmaceutical Company Limited
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering Takeda Pharmaceutical Company Limited
Jefferies & Co. | |
TD Cowen | |
BofA Securities | |
Cowen | |
Morgan Stanley |
EPS Revisions
- Stock Market
- Equities
- 4502 Stock
- TAK Stock
- Consensus Takeda Pharmaceutical Company Limited